CCL2 and COVID-19: Severe COVID-19 patients show a notable elevation of inflammatory cytokines such as IL-2R, IL-6, granulocyte colony-stimulating factor (GCSF), macrophage chemotactic protein-1 (MCP1), macrophage inflammatory protein (MIP)1A, TNF-α and anti-inflammatory compounds such as CRP [10, 92].